Prevention and management of lung cancer in China (Q26786585)

2

0 references

Gui-Sheng Qian

3

0 references

Cheng-Ping Hu

4

0 references

Jian-Ying Zhou

5

0 references

Liang-An Chen

6

0 references

Wei-Min Li

7

0 references

Shi-Yue Li

8

0 references

Kai Wang

9

0 references

Qi Wang

10

0 references

Xiao-Ju Zhang

11

0 references

Jing Li

12

0 references

Xin Gong

13

0 references

Chun-Xue Bai

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

14

0 references

language of work or name

English

0 references

publication date

1 September 2015

0 references

published in

Cancer

0 references

volume

121 Suppl 17

0 references

page(s)

3080-8

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29584

Association of the Asp312Asn and Lys751Gln polymorphisms in the XPD gene with the risk of non-Hodgkin's lymphoma: evidence from a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29584

Global cancer statistics, 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29584

Carcinogenicity of household solid fuel combustion and of high-temperature frying

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29584

COPD in China: the burden and importance of proper management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29584

Environmental health in China: progress towards clean air and safe water

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29584

Inhalation exposure to ambient polycyclic aromatic hydrocarbons and lung cancer risk of Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29584

A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29584

Lung Adenocarcinoma From East Asian Never-Smokers Is a Disease Largely Defined by Targetable Oncogenic Mutant Kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29584

Tobacco tightrope--balancing disease prevention and economic development in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29584

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29584

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29584

Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29584

Prevalence of undiagnosed and undertreated chronic obstructive pulmonary disease in lung cancer population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29584

Prior lung disease and lung cancer risk in an occupational-based cohort in Yunnan, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29584

Multicenter analysis of lung cancer patients younger than 45 years in Shanghai

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29584

inferred from DOI database lookup

7 January 2021

based on heuristic

Previous pulmonary diseases and risk of lung cancer in Gansu Province, China

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29584